Picture of Aridis Pharmaceuticals logo

ARDS Aridis Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

U.S. STOCKS ON THE MOVE-Epizyme, National Security, Lendingclub

Wall Street was set to open higher on Thursday, helped by gains in megacap
tech-focused firms a day after hawkish comments from the Federal Reserve weighed
on markets.  .N 
    At 9:19 a.m. ET, Dow e-minis  1YMc1  were up 0.59% at 34,257. S&P 500
e-minis  ESc1  were up 0.91% at 4,381, while Nasdaq 100 e-minis  NQc1  were up
1.15% at 14,320.75.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** BigBear.ai Holdings Inc  BBAI.K , up 14.2%
 ** Servicenow Inc  NOW , up 13.3%
 ** Marinemax Inc  HZO , up 12.5%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Lendingclub Corp  LC , down 18.6%
 ** Zymeworks Inc  ZYME.K , down 11.1%
 ** Weidai Ltd  WEI , down 9.4%
 
 The top two Nasdaq percentage gainers premarket  .PRPG.O :
 ** National Security Group Inc  NSEC.O , up 62.7%
 ** Aridis Pharmaceuticals Inc  ARDS.O , up 25.3%
 
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Epizyme Inc  EPZM.O , down 32.1%
 ** 1-800-Flowers.Com Inc  FLWS.O , down 30.2%
 ** Biosig Technologies Inc  BSGM.O , down 21.6%
 
 
 ** Netflix Inc  NFLX.O : up 5.1% premarket
 BUZZ-Ackman's stake reveal lifts Netflix shares off nearly 2-yr lows
 urn:newsml:reuters.com:*:nL4N2U72XD
 
 ** Intel Corp  INTC.O : down 3.2% premarket
 BUZZ-Street View: Intel on growth path despite margin pressure  urn:newsml:reuters.com:*:nL4N2U72UC
 
 ** Block  SQ.N : down 2.2% premarket
 BUZZ-Block drops on report small businesses can use iPhones to accept payments
 urn:newsml:reuters.com:*:nL4N2U735P
 
 ** Xilinx  XLNX.O : up 7.9% premarket
 BUZZ-Xilinx jumps on strong results, greenlight for AMD deal  urn:newsml:reuters.com:*:nL4N2U7375
 
 ** Epizyme Inc  EPZM.O : down 32.1% premarket
 BUZZ-Epizyme plummets on deep-discounted stock deal  urn:newsml:reuters.com:*:nL1N2U7123
 
 ** Seagate Technology  STX.O : up 10.1% premarket
 BUZZ-Seagate Technology rises on Q2 revenue, profit beat  urn:newsml:reuters.com:*:nL4N2U737X
 
 ** Moderna  MRNA.O : up 3.3% premarket
 BUZZ- Up on starting trial for Omicron-specific booster shot  urn:newsml:reuters.com:*:nL4N2U7385
 
 ** Edwards Lifesciences'  EW.N : down 5.8% premarket
 BUZZ- Falls as Q4 earnings disappoint  urn:newsml:reuters.com:*:nL4N2U738K
 
 ** ServiceNow  NOW.N : up 13.3% premarket
 BUZZ- Eyes best session in 22 months on upbeat Q4  urn:newsml:reuters.com:*:nL4N2U737Q
 
 ** National Security Group  NSEC.O : up 62.7% premarket
 BUZZ- Surges on $41 mln takeover offer  urn:newsml:reuters.com:*:nL4N2U739G
 
 ** Intel  INTC.O : down 3.2% premarket
 BUZZ-Slides after underwhelming forecast  urn:newsml:reuters.com:*:nL4N2U739Q
 
 ** Teradyne  TER.O : down 20.0% premarket
 BUZZ-Drops on weak Q1 earnings guidance  urn:newsml:reuters.com:*:nL4N2U73AQ
 
 ** Aridis Pharma  ARDS.O : up 25.3% premarket
 BUZZ-Gains on Gates foundation funding for COVID-19 therapy  urn:newsml:reuters.com:*:nL4N2U73EH
 
 ** McDonald's  MCD.N : down 1.5% premarket
 BUZZ-Falls after Q4 revenue, profit miss estimates  urn:newsml:reuters.com:*:nL4N2U73FS 
 
 ** AT&T Inc  T.N : down 0.4% premarket
 BUZZ-Street View: Needs to act better to achieve bigger goals  urn:newsml:reuters.com:*:nL4N2U73EO 
 
 ** Meta Platform Inc  FB.O : up 1.4% premarket
 BUZZ-Crypto venture to unwind, sell technology to Silvergate [BUZZ-Facebook's
crypto venture to unwind, sell technology to Silvergate ] 
    
  ** Tractor Supply Co  TSCO.O : up 5.5% premarket
 BUZZ-Shares rev up as 2022 forecast tops estimates  urn:newsml:reuters.com:*:nL4N2U73SS 
 
 ** DouYu International Holdings Ltd  DOYU.O : up 7.7% premarket
 BUZZ-Jumps on Reuters report of Tencent's take-private plan  urn:newsml:reuters.com:*:nL4N2U73UO
    
 ** Textron Inc  TXT.N : up 0.3% premarket
 BUZZ-Drops to near two-month lows on weak Q4 earnings, FY guidance urn:newsml:reuters.com:*:nL4N2U73KH 
         

 (Compiled by Nathan Gomes in Bengaluru)
 ((Nathan.gomes@thomsonreuters.com))

Recent news on Aridis Pharmaceuticals

See all news